Angiogenesis Modulators Market Report

China Angiogenesis Modulators Industry Market Research Report 2023-2029

  • POSTDATE：Aug 30, 2023
  • PAGES：169
  • REPORT CODE：GMM1766051
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Angiogenesis Modulators industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bayer Healthcare AG

    • Progen Pharmaceuticals Ltd

    • Angiotech Pharmaceuticals, Inc

    • Chugai Pharmaceutical Co, Ltd

    • Merck & Co, Inc

    • Amgen, Inc

    • Silence Therapeutics plc

    • Astrazeneca plc

    • OXiGENE, Inc

    • ThromboGenics, Inc

    • FHoffmann-La Roche Ltd

    • Bristol-Myers Squibb Company

    • Antisoma plc

    • Merck KGaA

    • Genvec, Inc

    • Eli Lilly and Company

    • Eye-Tech Inc

    • GlaxoSmithKline plc

    • Genentech, Inc

    • Cardium Therapeutics, Inc

    • Aeterna Zentaris Inc

    • Imclone Systems, Inc

    • Genzyme Corporation

    • Ångstrom Pharmaceuticals, Inc

    • Celgene Corporation

    • Alcon, Inc

    By Type:

    • Angiogenin

    • Angiogenesis Inhibitors

    • Angiogenesis Stimulators

    • Others

    By Application:

    • Cardiology

    • Ophthalmology

    • Cancer

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Angiogenesis Modulators Market Overview 2018-2029

    • 1.1 China Angiogenesis Modulators Industry Development Overview

    • 1.2 China Angiogenesis Modulators Industry Development History

    • 1.3 China Angiogenesis Modulators Industry Market Size (2018-2029)

    • 1.4 China Angiogenesis Modulators Market Analysis by Type from Production Side

      • 1.4.1 China Angiogenesis Modulators Production Volume, Production Value and Growth Rate of Angiogenin (2018-2029)

      • 1.4.2 China Angiogenesis Modulators Production Volume, Production Value and Growth Rate of Angiogenesis Inhibitors (2018-2029)

      • 1.4.3 China Angiogenesis Modulators Production Volume, Production Value and Growth Rate of Angiogenesis Stimulators (2018-2029)

      • 1.4.4 China Angiogenesis Modulators Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Angiogenesis Modulators Market Analysis by Application from Consumption End

      • 1.5.1 China Angiogenesis Modulators Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)

      • 1.5.2 China Angiogenesis Modulators Sales Volume, Sales Value and Growth Rate of Ophthalmology (2018-2029)

      • 1.5.3 China Angiogenesis Modulators Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

      • 1.5.4 China Angiogenesis Modulators Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Angiogenesis Modulators Market Analysis by Region

      • 1.6.1 North China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

    Chapter 2 China Angiogenesis Modulators Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Angiogenesis Modulators Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Angiogenesis Modulators Market Status and Competition Analysis in 2023

      • 2.2.3 China Angiogenesis Modulators Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Angiogenesis Modulators Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Angiogenesis Modulators Industry Development

    Chapter 3 Angiogenesis ModulatorsIndustry Chain Analysis

    • 3.1 Angiogenesis Modulators Industry Chain

    • 3.2 Angiogenesis Modulators Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Angiogenesis Modulators Market

    • 3.3 Angiogenesis Modulators Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Angiogenesis Modulators Market

    Chapter 4 China Angiogenesis Modulators Market, by Type

    • 4.1 China Angiogenesis Modulators Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Angiogenesis Modulators Total Production Volume and Growth Rate from Production Side

    • 4.5 China Angiogenesis Modulators Production Volume and Growth Rate, by Type

      • 4.5.1 China Angiogenesis Modulators Production Volume and Growth Rate of Angiogenin

      • 4.5.2 China Angiogenesis Modulators Production Volume and Growth Rate of Angiogenesis Inhibitors

      • 4.5.3 China Angiogenesis Modulators Production Volume and Growth Rate of Angiogenesis Stimulators

      • 4.5.4 China Angiogenesis Modulators Production Volume and Growth Rate of Others

    Chapter 5 China Angiogenesis Modulators Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Angiogenesis Modulators Total Market Size and Growth Rate from Consumption End

    • 5.5 China Angiogenesis Modulators Market Size and Growth Rate, by Application

      • 5.5.1 China Angiogenesis Modulators Market Size and Growth Rate of Cardiology

      • 5.5.2 China Angiogenesis Modulators Market Size and Growth Rate of Ophthalmology

      • 5.5.3 China Angiogenesis Modulators Market Size and Growth Rate of Cancer

      • 5.5.4 China Angiogenesis Modulators Market Size and Growth Rate of Others

    Chapter 6 China Angiogenesis Modulators Market, by Region

    • 6.1 China Angiogenesis Modulators Production Volume and Production Value, by Region

    • 6.2 China Angiogenesis Modulators Sales Volume and Sales Value, by Region

    Chapter 7 North China Angiogenesis Modulators Market Analysis

    • 7.1 North China Angiogenesis Modulators Market, by Type

    • 7.2 North China Angiogenesis Modulators Market, by Application

    Chapter 8 Central China Angiogenesis Modulators Market Analysis

    • 8.1 Central China Angiogenesis Modulators Market, by Type

    • 8.2 Central China Angiogenesis Modulators Market, by Application

    Chapter 9 South China Angiogenesis Modulators Market Analysis

    • 9.1 South China Angiogenesis Modulators Market, by Type

    • 9.2 South China Angiogenesis Modulators Market, by Application

    Chapter 10 East China Angiogenesis Modulators Market Analysis

    • 10.1 East China Angiogenesis Modulators Market, by Type

    • 10.2 East China Angiogenesis Modulators Market, by Application

    Chapter 11 Northeast China Angiogenesis Modulators Market Analysis

    • 11.1 Northeast China Angiogenesis Modulators Market, by Type

    • 11.2 Northeast China Angiogenesis Modulators Market, by Application

    Chapter 12 Southwest China Angiogenesis Modulators Market Analysis

    • 12.1 Southwest China Angiogenesis Modulators Market, by Type

    • 12.2 Southwest China Angiogenesis Modulators Market, by Application

    Chapter 13 Northwest China Angiogenesis Modulators Market Analysis

    • 13.1 Northwest China Angiogenesis Modulators Market, by Type

    • 13.2 Northwest China Angiogenesis Modulators Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bayer Healthcare AG

        • 14.1.1 Bayer Healthcare AG Company Profile

        • 14.1.2 Bayer Healthcare AG Angiogenesis Modulators Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Progen Pharmaceuticals Ltd

        • 14.2.1 Progen Pharmaceuticals Ltd Company Profile

        • 14.2.2 Progen Pharmaceuticals Ltd Angiogenesis Modulators Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Angiotech Pharmaceuticals, Inc

        • 14.3.1 Angiotech Pharmaceuticals, Inc Company Profile

        • 14.3.2 Angiotech Pharmaceuticals, Inc Angiogenesis Modulators Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Chugai Pharmaceutical Co, Ltd

        • 14.4.1 Chugai Pharmaceutical Co, Ltd Company Profile

        • 14.4.2 Chugai Pharmaceutical Co, Ltd Angiogenesis Modulators Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Merck & Co, Inc

        • 14.5.1 Merck & Co, Inc Company Profile

        • 14.5.2 Merck & Co, Inc Angiogenesis Modulators Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Amgen, Inc

        • 14.6.1 Amgen, Inc Company Profile

        • 14.6.2 Amgen, Inc Angiogenesis Modulators Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Silence Therapeutics plc

        • 14.7.1 Silence Therapeutics plc Company Profile

        • 14.7.2 Silence Therapeutics plc Angiogenesis Modulators Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Astrazeneca plc

        • 14.8.1 Astrazeneca plc Company Profile

        • 14.8.2 Astrazeneca plc Angiogenesis Modulators Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 OXiGENE, Inc

        • 14.9.1 OXiGENE, Inc Company Profile

        • 14.9.2 OXiGENE, Inc Angiogenesis Modulators Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 ThromboGenics, Inc

        • 14.10.1 ThromboGenics, Inc Company Profile

        • 14.10.2 ThromboGenics, Inc Angiogenesis Modulators Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 FHoffmann-La Roche Ltd

        • 14.11.1 FHoffmann-La Roche Ltd Company Profile

        • 14.11.2 FHoffmann-La Roche Ltd Angiogenesis Modulators Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Bristol-Myers Squibb Company

        • 14.12.1 Bristol-Myers Squibb Company Company Profile

        • 14.12.2 Bristol-Myers Squibb Company Angiogenesis Modulators Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Antisoma plc

        • 14.13.1 Antisoma plc Company Profile

        • 14.13.2 Antisoma plc Angiogenesis Modulators Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Merck KGaA

        • 14.14.1 Merck KGaA Company Profile

        • 14.14.2 Merck KGaA Angiogenesis Modulators Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Genvec, Inc

        • 14.15.1 Genvec, Inc Company Profile

        • 14.15.2 Genvec, Inc Angiogenesis Modulators Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Eli Lilly and Company

        • 14.16.1 Eli Lilly and Company Company Profile

        • 14.16.2 Eli Lilly and Company Angiogenesis Modulators Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Eye-Tech Inc

        • 14.17.1 Eye-Tech Inc Company Profile

        • 14.17.2 Eye-Tech Inc Angiogenesis Modulators Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 GlaxoSmithKline plc

        • 14.18.1 GlaxoSmithKline plc Company Profile

        • 14.18.2 GlaxoSmithKline plc Angiogenesis Modulators Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Genentech, Inc

        • 14.19.1 Genentech, Inc Company Profile

        • 14.19.2 Genentech, Inc Angiogenesis Modulators Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Cardium Therapeutics, Inc

        • 14.20.1 Cardium Therapeutics, Inc Company Profile

        • 14.20.2 Cardium Therapeutics, Inc Angiogenesis Modulators Market Performance

        • 14.20.3 Product&Service Introduction

      • 14.21 Aeterna Zentaris Inc

        • 14.21.1 Aeterna Zentaris Inc Company Profile

        • 14.21.2 Aeterna Zentaris Inc Angiogenesis Modulators Market Performance

        • 14.21.3 Product&Service Introduction

      • 14.22 Imclone Systems, Inc

        • 14.22.1 Imclone Systems, Inc Company Profile

        • 14.22.2 Imclone Systems, Inc Angiogenesis Modulators Market Performance

        • 14.22.3 Product&Service Introduction

      • 14.23 Genzyme Corporation

        • 14.23.1 Genzyme Corporation Company Profile

        • 14.23.2 Genzyme Corporation Angiogenesis Modulators Market Performance

        • 14.23.3 Product&Service Introduction

      • 14.24 Ångstrom Pharmaceuticals, Inc

        • 14.24.1 Ångstrom Pharmaceuticals, Inc Company Profile

        • 14.24.2 Ångstrom Pharmaceuticals, Inc Angiogenesis Modulators Market Performance

        • 14.24.3 Product&Service Introduction

      • 14.25 Celgene Corporation

        • 14.25.1 Celgene Corporation Company Profile

        • 14.25.2 Celgene Corporation Angiogenesis Modulators Market Performance

        • 14.25.3 Product&Service Introduction

      • 14.26 Alcon, Inc

        • 14.26.1 Alcon, Inc Company Profile

        • 14.26.2 Alcon, Inc Angiogenesis Modulators Market Performance

        • 14.26.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Angiogenesis Modulators Industry Research Conclusions

    • 15.2 Angiogenesis Modulators Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Angiogenesis Modulators Industry Market Size (2018-2029)

    • Figure China Angiogenesis Modulators Production Volume, Production Value and Growth Rate of Angiogenin (2018-2029)

    • Figure China Angiogenesis Modulators Production Volume, Production Value and Growth Rate of Angiogenesis Inhibitors (2018-2029)

    • Figure China Angiogenesis Modulators Production Volume, Production Value and Growth Rate of Angiogenesis Stimulators (2018-2029)

    • Figure China Angiogenesis Modulators Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Angiogenesis Modulators Sales Volume, Sales Value and Growth Rate of Cardiology (2018-2029)

    • Figure China Angiogenesis Modulators Sales Volume, Sales Value and Growth Rate of Ophthalmology (2018-2029)

    • Figure China Angiogenesis Modulators Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • Figure China Angiogenesis Modulators Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

    • Figure Central China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

    • Figure South China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

    • Figure East China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Angiogenesis Modulators Market Size and Growth Rate from 2018-2029

    • Figure Angiogenesis Modulators Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Angiogenesis Modulators Market Share by Type in 2018

    • Figure China Angiogenesis Modulators Market Share by Type in 2023

    • Figure China Angiogenesis Modulators Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Angiogenesis Modulators Production Volume and Growth Rate of Angiogenin (2018-2023)

    • Figure China Angiogenesis Modulators Production Volume and Growth Rate of Angiogenesis Inhibitors (2018-2023)

    • Figure China Angiogenesis Modulators Production Volume and Growth Rate of Angiogenesis Stimulators (2018-2023)

    • Figure China Angiogenesis Modulators Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Angiogenesis Modulators Market Share by Application in 2018

    • Figure China Angiogenesis Modulators Market Share by Application in 2023

    • Figure China Angiogenesis Modulators Total Market Size and Growth Rate from Consumption End

    • Figure China Angiogenesis Modulators Market Size and Growth Rate of Cardiology (2018-2023)

    • Figure China Angiogenesis Modulators Market Size and Growth Rate of Ophthalmology (2018-2023)

    • Figure China Angiogenesis Modulators Market Size and Growth Rate of Cancer (2018-2023)

    • Figure China Angiogenesis Modulators Market Size and Growth Rate of Others (2018-2023)

    • Table China Angiogenesis Modulators Production Volume by Region (2018-2023)

    • Table China Angiogenesis Modulators Production Volume Share by Region (2018-2023)

    • Figure China Angiogenesis Modulators Production Volume Share by Region (2018-2023)

    • Table China Angiogenesis Modulators Production Value by Region (2018-2023)

    • Table China Angiogenesis Modulators Production Value Share by Region (2018-2023)

    • Figure China Angiogenesis Modulators Production Value Share by Region (2018-2023)

    • Table China Angiogenesis Modulators Sales Volume by Region (2018-2023)

    • Table China Angiogenesis Modulators Sales Volume Share by Region (2018-2023)

    • Figure China Angiogenesis Modulators Sales Volume Share by Region (2018-2023)

    • Table China Angiogenesis Modulators Sales Value by Region (2018-2023)

    • Table China Angiogenesis Modulators Sales Value Share by Region (2018-2023)

    • Figure China Angiogenesis Modulators Sales Value Share by Region (2018-2023)

    • Table North China Angiogenesis Modulators Production Volume by Type (2018-2023)

    • Table North China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Figure North China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Table North China Angiogenesis Modulators Sales Volume by Application (2018-2023)

    • Table North China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Figure North China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Table Central China Angiogenesis Modulators Production Volume by Type (2018-2023)

    • Table Central China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Figure Central China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Table Central China Angiogenesis Modulators Sales Volume by Application (2018-2023)

    • Table Central China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Figure Central China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Table South China Angiogenesis Modulators Production Volume by Type (2018-2023)

    • Table South China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Figure South China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Table South China Angiogenesis Modulators Sales Volume by Application (2018-2023)

    • Table South China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Figure South China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Table East China Angiogenesis Modulators Production Volume by Type (2018-2023)

    • Table East China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Figure East China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Table East China Angiogenesis Modulators Sales Volume by Application (2018-2023)

    • Table East China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Figure East China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Table Northeast China Angiogenesis Modulators Production Volume by Type (2018-2023)

    • Table Northeast China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Figure Northeast China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Table Northeast China Angiogenesis Modulators Sales Volume by Application (2018-2023)

    • Table Northeast China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Table Southwest China Angiogenesis Modulators Production Volume by Type (2018-2023)

    • Table Southwest China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Figure Southwest China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Table Southwest China Angiogenesis Modulators Sales Volume by Application (2018-2023)

    • Table Southwest China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Table Northwest China Angiogenesis Modulators Production Volume by Type (2018-2023)

    • Table Northwest China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Figure Northwest China Angiogenesis Modulators Production Volume Share by Type (2018-2023)

    • Table Northwest China Angiogenesis Modulators Sales Volume by Application (2018-2023)

    • Table Northwest China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Angiogenesis Modulators Sales Volume Share by Application (2018-2023)

    • Table Bayer Healthcare AG Company Profile

    • Table Bayer Healthcare AG Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Progen Pharmaceuticals Ltd Company Profile

    • Table Progen Pharmaceuticals Ltd Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Angiotech Pharmaceuticals, Inc Company Profile

    • Table Angiotech Pharmaceuticals, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Chugai Pharmaceutical Co, Ltd Company Profile

    • Table Chugai Pharmaceutical Co, Ltd Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc Company Profile

    • Table Merck & Co, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Amgen, Inc Company Profile

    • Table Amgen, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Silence Therapeutics plc Company Profile

    • Table Silence Therapeutics plc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Astrazeneca plc Company Profile

    • Table Astrazeneca plc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table OXiGENE, Inc Company Profile

    • Table OXiGENE, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table ThromboGenics, Inc Company Profile

    • Table ThromboGenics, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table FHoffmann-La Roche Ltd Company Profile

    • Table FHoffmann-La Roche Ltd Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Company Profile

    • Table Bristol-Myers Squibb Company Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Antisoma plc Company Profile

    • Table Antisoma plc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Merck KGaA Company Profile

    • Table Merck KGaA Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Genvec, Inc Company Profile

    • Table Genvec, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly and Company Company Profile

    • Table Eli Lilly and Company Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Eye-Tech Inc Company Profile

    • Table Eye-Tech Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline plc Company Profile

    • Table GlaxoSmithKline plc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Genentech, Inc Company Profile

    • Table Genentech, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Cardium Therapeutics, Inc Company Profile

    • Table Cardium Therapeutics, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Aeterna Zentaris Inc Company Profile

    • Table Aeterna Zentaris Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Imclone Systems, Inc Company Profile

    • Table Imclone Systems, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Genzyme Corporation Company Profile

    • Table Genzyme Corporation Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Ångstrom Pharmaceuticals, Inc Company Profile

    • Table Ångstrom Pharmaceuticals, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Celgene Corporation Company Profile

    • Table Celgene Corporation Angiogenesis Modulators Revenue, Price and Gross (2018-2023)

    • Table Alcon, Inc Company Profile

    • Table Alcon, Inc Angiogenesis Modulators Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US